Molecular diagnostics is an interactive two day program that includes government and industry speakers addressing current regulatory, reimbursement and legislative topics in the evolving field of molecular diagnostics. Attendees will participate in sessions ranging from the latest government policies aimed at molecular diagnostics, healthcare reform and implications for diagnostics; FDA oversight and regulation of molecular diagnostics; key regulatory considerations in developing molecular diagnostics and what it takes to make to create a good submission; developments impacting personalized medicine; co-development and the future of companion diagnostics; the changing landscape of molecular diagnostics reimbursement; and an afternoon on future proposals that could foster the introduction of new molecular diagnostics.

More Information